ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

NKTR Nektar Therapeutics

1.33
0.01 (0.76%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Nektar Therapeutics NKTR NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.01 0.76% 1.33 09:00:00
始値 安値 高値 終値 前日終値
1.33 1.31 1.38 1.33 1.32
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/2303:00PRNUSNektar Management to Present at the H.C. Wainwright 2nd..
2024/3/0607:11EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0523:00PRNUSNektar Therapeutics Announces Initiation of Phase 2b..
2024/3/0506:20EDGAR2Form 8-K - Current report
2024/3/0506:15PRNUSNektar Therapeutics Reports Fourth Quarter and Year-End 2023..
2024/3/0422:40EDGAR2Form 8-K - Current report
2024/3/0422:30PRNUSNektar Therapeutics Announces $30 Million Private Placement..
2024/2/2808:00PRNUSNektar Management to Present at the TD Cowen 44th Annual..
2024/2/2708:00PRNUSNektar to Announce Financial Results for the Fourth Quarter..
2024/2/2310:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2310:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2310:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2105:55EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2105:51EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2105:50EDGAR2Form 144 - Report of proposed sale of securities
2024/2/1707:16EDGAR2Form 8-K - Current report
2024/2/1507:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1422:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/1106:25EDGAR2Form 8-K - Current report
2024/1/0408:00PRNUSNektar Management To Present at the 42nd Annual J.P. Morgan..
2023/12/1608:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1608:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1608:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1602:18EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1208:00PRNUSNektar and Collaborators Present Preclinical Data on..
2023/11/2806:55EDGAR2Form 8-K - Current report
2023/11/2111:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2111:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2110:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1806:36EDGAR2Form 144 - Report of proposed sale of securities
2023/11/1806:15EDGAR2Form 144 - Report of proposed sale of securities
2023/11/1806:10EDGAR2Form 144 - Report of proposed sale of securities
2023/11/0806:21EDGAR2Form 8-K - Current report
2023/11/0806:15PRNUSNektar Therapeutics Reports Third Quarter 2023 Financial..
2023/11/0107:00PRNUSNektar to Announce Financial Results for the Third Quarter..
2023/10/1321:30PRNUSNektar Presents New Responder Data for Rezpegaldesleukin, a..
2023/10/0222:00PRNUSNektar Therapeutics Announces Two Abstracts Accepted at EADV..
2023/9/2722:00PRNUSNektar Therapeutics Announces New Clinical Study..
2023/9/2209:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2109:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2109:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2109:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2109:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2109:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1906:06EDGAR2Form 144 - Report of proposed sale of securities
2023/9/1322:00PRNUSNektar Therapeutics Announces Promising New Data from Phase..
2023/9/0906:16EDGAR2Form 8-K - Current report
2023/9/0707:00PRNUSNektar Therapeutics to Host Virtual Investor & Analyst Event..
2023/8/1809:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1809:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock